Sean Brynjelsen
EVP, Business Development, Sagent Pharmaceuticals, Inc.
Companies
- Eton Pharmaceuticals, Inc.Board member Nov 13, 2018 to now1
- Eton Pharmaceuticals, Inc.Chief executive officer Nov 13, 2018 to now1
- Eton Pharmaceuticals, Inc.President Nov 13, 2018 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Eton Pharmaceuticals, Inc. ETON986,134 shares2$48.9M at $49.62Aug 20, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 20, 2026Sold 7,342 shares at $62.12 of Eton Pharmaceuticals, Inc.2
- Aug 20, 2026Sold 36,373 shares at $61.11 of Eton Pharmaceuticals, Inc.2
- Aug 20, 2026Sold 47,307 shares at $60.17 of Eton Pharmaceuticals, Inc.2
- Aug 19, 2026Sold 8,978 shares at $62.65 of Eton Pharmaceuticals, Inc.2
- Jul 14, 2026Exercised options 200,000 shares at $1.37 of Eton Pharmaceuticals, Inc.3
- Jul 12, 2026Exercised options 27,500 shares of Eton Pharmaceuticals, Inc.3
- May 28, 2026Sold 148 shares at $32.67 of Eton Pharmaceuticals, Inc.4
- May 28, 2026Sold 119,852 shares at $31.88 of Eton Pharmaceuticals, Inc.4
- Jan 1, 2026Shares withheld for tax 5,015 shares at $15.39 of Eton Pharmaceuticals, Inc.5
- Dec 12, 2025Shares withheld for tax 6,732 shares at $16.83 of Eton Pharmaceuticals, Inc.6
- Jun 5, 2025Sold 70,000 shares at $16.81 of Eton Pharmaceuticals, Inc.7
- Jun 4, 2025Sold 70,000 shares at $17.00 of Eton Pharmaceuticals, Inc.7
- Jun 3, 2025Sold 400 shares at $19.02 of Eton Pharmaceuticals, Inc.7
- Jun 3, 2025Sold 8,655 shares at $18.38 of Eton Pharmaceuticals, Inc.7
- Jun 3, 2025Sold 60,945 shares at $17.38 of Eton Pharmaceuticals, Inc.7
- Sep 22, 2022Bought 10,000 shares at $2.10 of Eton Pharmaceuticals, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jul 14, 2026
- 4SEC EDGARForm 4 filed May 29, 2026
- 5SEC EDGARForm 4 filed Jan 14, 2026
- 6SEC EDGARForm 4 filed Dec 12, 2025
- 7SEC EDGARForm 4 filed Jun 5, 2025
- 8SEC EDGARForm 4 filed Sep 23, 2022